Indian diabetic population on Human Mixtard concerned on changes in insulin therapy: Nandita Vijayasimha, Bengaluru Thursday, April 24, 2025, 08:00 Hrs [IST] India’s diabetic po ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

I’m an old dog. There’s no denying it. I like to do things the way I have always done them. But I also like to keep current ...

Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...

More research is necessary, but cold plunges have been linked to several potential benefits, like improving circulation and ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

Oral hormone therapy may benefit heart health in menopausal women. A new analysis of data from the Women's Health Initiative found that estrogen-based oral hormone therapy had a long-term beneficial ...

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Cannabis interacts with the body’s endocannabinoid system, which plays a role in regulating glucose and lipid metabolism, ...

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...

Metabolic syndrome is a major global health concern, encompassing interconnected conditions such as obesity, hypertension, ...